Purchases and Sales Made in Q3 2024 in Ultragenyx Pharmaceutical Inc. (RARE)
This table provides information about the institutional ownership of Ultragenyx Pharmaceutical Inc. (RARE) during Q3 2024. The information is specifically focused on institutions that hold shares of Ultragenyx Pharmaceutical Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 13, 2024
Q3 2024
|
Sands Capital Management, LLC
Arlington, VA |
SELL
|
- |
-236K- 4.42% |
$9.51M - $14M
|
5.12M
$212M
|
|
|
Nov 13, 2024
Q3 2024
|
First Trust Advisors LP
Wheaton, IL |
SELL
|
- |
-264K- 93.94% |
$10.6M - $15.7M
|
17K
$705K
|
|
|
Nov 14, 2024
Q3 2024
|
Man Group PLC
London, X0 |
SELL
|
- |
-302K- 47.96% |
$12.1M - $17.9M
|
327K
$13.6M
|
|
|
Nov 14, 2024
Q3 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-311K- 27.45% |
$12.5M - $18.5M
|
822K
$34.1M
|
|
|
Nov 14, 2024
Q3 2024
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-316K- 44.09% |
$12.7M - $18.8M
|
401K
$16.6M
|
|
|
Nov 14, 2024
Q3 2024
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-341K- 87.42% |
$13.7M - $20.3M
|
49.1K
$2.04M
|
|
|
Nov 14, 2024
Q3 2024
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-391K- 8.58% |
$15.7M - $23.2M
|
4.17M
$173M
|
|
|
Nov 14, 2024
Q3 2024
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
SELL
|
- |
-536K- 84.56% |
$21.6M - $31.8M
|
98K
$4.06M
|
|
|
Nov 14, 2024
Q3 2024
|
Suvretta Capital Management, LLC
New York, NY |
SELL
|
- |
-910K- 44.15% |
$36.6M - $54M
|
1.15M
$47.7M
|
|
|
Nov 14, 2024
Q3 2024
|
Vestal Point Capital, LP
New York, NY |
SELL
|
- |
-1.05M- 58.33% |
$42.2M - $62.3M
|
750K
$31.1M
|
|
|
Nov 14, 2024
Q3 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-1.14M- 61.6% |
$45.8M - $67.7M
|
711K
$29.5M
|
|
|
Nov 14, 2024
Q3 2024
|
Rtw Investments, LP
New York, NY |
SELL
|
- |
-1.29M- 39.63% |
$51.9M - $76.7M
|
1.97M
$81.6M
|